Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

SHARPIN regulates immune signaling and contributes to full transcriptional activity and prevention of cell death in response to TNF in vitro. The inactivating mouse Sharpin cpdm mutation causes TNF-dependent multi-organ inflammation, characterized by dermatitis, liver inflammation, splenomegaly, and loss of Peyer's patches. TNF-dependent cell death has been proposed to cause the inflammatory phenotype and consistent with this we show Tnfr1, but not Tnfr2, deficiency suppresses the phenotype (and it does so more efficiently than Il1r1 loss). TNFR1-induced apoptosis can proceed through caspase-8 and BID, but reduction in or loss of these players generally did not suppress inflammation, although Casp8 heterozygosity significantly delayed dermatitis. Ripk3 or Mlkl deficiency partially ameliorated the multi-organ phenotype, and combined Ripk3 deletion and Casp8 heterozygosity almost completely suppressed it, even restoring Peyer's patches. Unexpectedly, Sharpin, Ripk3 and Casp8 triple deficiency caused perinatal lethality. These results provide unexpected insights into the developmental importance of SHARPIN.

Original publication

DOI

10.7554/eLife.03464

Type

Journal article

Journal

Elife

Publication Date

02/12/2014

Volume

3

Keywords

LUBAC, TNF signaling, apoptosis, cell biology, dermatitis, developmental biology, inflammation, mouse, stem cells, ubiquitin, Animals, Caspase 3, Caspase 8, Cell Death, Cells, Cultured, Chronic Disease, Cytoprotection, Dermatitis, Fibroblasts, Heterozygote, Inflammation, Keratinocytes, Liver, Macrophages, Mice, Inbred C57BL, Myeloid Cells, Nerve Tissue Proteins, Receptor-Interacting Protein Serine-Threonine Kinases, Receptors, Interleukin-1, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II, Spleen, Tumor Necrosis Factor-alpha, Ubiquitin-Protein Ligases, Ubiquitination